Among the upregulated DEPs, S100A8 is highly overexpressed in multifarious tumors and can promote the initiation and progression of cancers by regulating tumor cell movement, proliferation, differentiation, apoptosis and drug resistance (38–40). Here, S100A8 is linked to cancer.